Union Korea Pharm Co., Ltd. (KOSDAQ:080720)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,175.00
-930.00 (-10.21%)
At close: Oct 11, 2024

Union Korea Pharm Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
37,0323,1244,3246,5796,01220,659
Short-Term Investments
400.023,4561,437602.131,513461.34
Cash & Short-Term Investments
37,4326,5815,7617,1817,52421,120
Cash Growth
775.66%14.23%-19.77%-4.57%-64.37%573.86%
Accounts Receivable
5,8137,46220,43533,52033,09226,147
Other Receivables
880.571,008377.44748.69631.13644.7
Receivables
6,6938,47020,81234,26933,72326,792
Inventory
7,5385,38712,8807,91012,73110,747
Prepaid Expenses
96.29142.42152.3891.9976.3969.3
Other Current Assets
1,309970.37597.6230.35515.553.99
Total Current Assets
53,06921,55040,20249,68354,57058,782
Property, Plant & Equipment
21,66721,77928,65934,59644,61343,787
Long-Term Investments
662.99624.961,5342,6172,4502,454
Other Intangible Assets
561.21609.8742.141,0811,5391,751
Long-Term Deferred Tax Assets
--3,0374,9738,71010,564
Other Long-Term Assets
1,6361,272585.291,266399.861,436
Total Assets
77,59645,83674,91094,425112,523119,044

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,1635,4553,4072,8843,0802,697
Accrued Expenses
1,1043,5501,4571,5741,013950.45
Short-Term Debt
5,00018,10020,48834,90233,96610,500
Current Portion of Long-Term Debt
-2,9883,0001,200-4,000
Current Portion of Leases
136.47249.48273.55167.26127.24280
Other Current Liabilities
34,57333,58135,37718,28220,80624,793
Total Current Liabilities
41,97663,92464,00359,00958,99243,220
Long-Term Debt
---3,0003,00021,026
Long-Term Leases
74.2896.07230.9980.1331.7961.48
Pension & Post-Retirement Benefits
1,5721,3531,8591,5261,278615.43
Other Long-Term Liabilities
296.853,365611.17486.02608.58522.72
Total Liabilities
43,92068,73766,70464,10163,91065,445

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
39,9273,9563,9563,9553,9523,952
Additional Paid-In Capital
67,19847,33947,33947,32447,29947,299
Retained Earnings
-64,991-65,739-34,977-13,7174,6545,663
Treasury Stock
-7,309-7,309-7,309-7,309-7,309-4,592
Comprehensive Income & Other
-1,148-1,148-804.3270.8816.3818.9
Total Common Equity
33,677-22,9018,20530,32448,61252,341
Shareholders' Equity
33,677-22,9018,20530,32448,61253,599
Total Liabilities & Equity
77,59645,83674,91094,425112,523119,044

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
5,21121,43323,99339,34937,12535,867
Net Cash (Debt)
32,222-14,853-18,232-32,169-29,601-14,747
Net Cash Growth
------
Net Cash Per Share
6026.76-6163.39-7567.77-13365.07-12034.97-5693.15
Filing Date Shares Outstanding
13.192.412.412.412.412.52
Total Common Shares Outstanding
13.192.412.412.412.412.52
Working Capital
11,093-42,373-23,801-9,327-4,42215,562
Book Value Per Share
2553.83-9503.343404.9112589.0120197.9120776.28
Tangible Book Value
33,115-23,5117,46329,24347,07350,590
Tangible Book Value Per Share
2511.27-9756.393096.9412140.4419558.4220081.30
Land
6,9056,9056,9056,9056,6816,656
Buildings
13,38613,71417,07819,81724,22325,073
Machinery
643.11636.421,2341,8853,4504,732
Construction In Progress
483.08130.52,9025,3829,1725,512